Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Submitted by
admin
on June 6, 2013 - 11:51am
Source:
Fierce Pharma
News Tags:
CytomX
Pfizer
antibody-drug conjugate
Headline:
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Do Not Allow Advertisers to Use My Personal information
